Given that Nashville-based Pathfinder Therapeutics' new CEO, Skip Goode (at left), was previously with Sunnyvale-based Accuray Incorporated (Nasdaq: ARAY), a mover in the field of radiosurgery, it is worth noting that Accuray is touting it has just installed its 10th CyberKnife(R) Robotic Radiosurgery System in an HCA facility, in this case Nashville's Sarah Cannon Cancer Center at CentennialMedical Center.
Wednesday, June 24, 2009
CyberKnife slices into HCA market
Given that Nashville-based Pathfinder Therapeutics' new CEO, Skip Goode (at left), was previously with Sunnyvale-based Accuray Incorporated (Nasdaq: ARAY), a mover in the field of radiosurgery, it is worth noting that Accuray is touting it has just installed its 10th CyberKnife(R) Robotic Radiosurgery System in an HCA facility, in this case Nashville's Sarah Cannon Cancer Center at CentennialMedical Center.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment